Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients.

Kidney Int · 2022 · PMC9006415 · PMID 35429496

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Belatacept use was associated with lower odds of developing neutralizing responses against the Delta variant, and although the odds ratio was similar for WT and the Omicron variant, it did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.